Today: Friday 6 August 2021 , 2:24 am


advertisment
search




Overview of Spondyloarthritis...medical consulting

Last updated 17 hour , 49 minute 38 Views

Advertisement
In this page talks about ( Overview of Spondyloarthritis...medical consulting ) It was sent to us on 05/08/2021 and was presented on 05/08/2021 and the last update on this page on 05/08/2021

Your Comment


Enter code


More Information about Spondyloarthritis













Arthritis Foundation





simple explanation



Spondyloarthritis (also called spondyloarthropathy or spondyloarthritides) is a term used to describe a group of connective tissue diseases that cause prominent joint inflammation. These diseases affect the joints and spine and share certain characteristics. For example they may cause back pain inflammation of the eye (uveitis) digestive symptoms and rashes. Some are strongly associated with the HLA-B27 gene. Because they cause many of the same problems and share genetic characteristics some experts think these disorders share similar causes and ways of causing symptoms.


Spondyloarthritis causes joint inflammation similar to rheumatoid arthritis. However in contrast to rheumatoid arthritis rheumatoid factor (see Blood tests) is negative in spondyloarthritis (hence these disorders are also called the seronegative spondyloarthropathies). These disorders include


Ankylosing spondylitis


Psoriatic arthritis


Reactive arthritis


Spondyloarthritis also can develop in association with digestive conditions (sometimes called enteropathic arthritis) such as inflammatory bowel disease intestinal bypass surgery or Whipple disease.


Juvenile-onset spondyloarthritis affects the lower extremities often affects joints on opposite sides of the body to different degrees and begins most commonly in boys aged 7 to 16.


Spondyloarthritis can also develop in people with no characteristics of other specific spondyloarthritis (undifferentiated spondyloarthritis). Treatment of undifferentiated spondyloarthritis is similar to treatment of reactive arthritis. The disease-modifying antirheumatic drugs (DMARDs) methotrexate and sulfasalazine may help relieve symptoms of spondyloarthritis. Sometimes tumor necrosis factor inhibitors or other biologic agents may be needed.


Arthritis Foundation
  • The Author: wikbe
 
Comments

There are no Comments yet

last seen